The role of cardiac resynchronization therapy for arterial switch operations complicated by complete heart block

Douglas Y Mah1, Mark E Alexander, Puja Banka

  • 1The Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts 02115, USA. douglas.mah@cardio.chboston.org

Insights

Left ventricular dysfunction after arterial switch operation for D-loop transposition of the great arteries with ventricular septal defects is uncommon. Heart block requiring pacemaker insertion was a risk factor, but cardiac resynchronization therapy improved function.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Surgery
  • Echocardiography

Background:

  • Focus on long-term outcomes like left ventricular (LV) dysfunction in D-loop transposition of the great arteries (D-TGA) post-arterial switch operation (ASO).
  • Investigating perioperative factors influencing LV dysfunction in D-TGA with ventricular septal defects (VSD) after ASO.

Purpose of the Study:

  • To identify perioperative risk factors for left ventricular dysfunction in pediatric patients with D-TGA/VSD undergoing ASO/VSD closure.
  • To evaluate the impact of interventions like cardiac resynchronization therapy (CRT) on LV function in this cohort.

Main Methods:

  • Retrospective analysis of 112 patients with D-TGA/VSD undergoing ASO/VSD closure (2001-2011).
  • Exclusion criteria included prematurity, L-looped ventricles, and straddling atrioventricular valves.
  • Primary endpoint: moderate/severe LV dysfunction by echocardiogram ≥2 months post-surgery.

Main Results:

  • Low incidence (8%) of moderate/severe LV dysfunction observed.
  • Significant risk factors identified: heart block requiring pacemaker (p<0.001) and prolonged ICU stay (p=0.04).
  • Upgrade to CRT improved LV function in patients with heart block and dysfunction.

Conclusions:

  • Left ventricular dysfunction is infrequent after D-TGA/VSD repair with ASO.
  • Heart block and pacemaker insertion are key risk factors for LV dysfunction.
  • Cardiac resynchronization therapy demonstrates efficacy in improving LV function post-operatively.
Abstract

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...